Siemens Health/€SHL

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Siemens Health

Siemens Healthineers AG, listed under the ticker SHL, operates in the healthcare sector and is particularly known for its innovative medical technology. The company, a segment of the larger Siemens Group, specializes in diagnostic and therapeutic products and services, including medical imaging, laboratory diagnostics, and point-of-care testing. Founded in 1847 as part of Siemens AG, Siemens Healthineers was spun off as a separate entity in 2018, reflecting its focus on healthcare technology and services.

Ticker

€SHL
Sector

Primary listing

XETRA

Employees

73,500

Siemens Health Metrics

BasicAdvanced
€54B
25.18
€1.93
0.75
€0.95
1.96%

What the Analysts think about Siemens Health

Analyst ratings (Buy, Hold, Sell) for Siemens Health stock.

Bulls say / Bears say

In Q3 2025, Siemens Healthineers posted a 7.6% rise in revenue year-over-year to €5.66 billion, surpassing analyst expectations and leading the company to increase its full-year comparable revenue growth forecast to 5.5–6% (Reuters)
The company’s adjusted free cash flow climbed 54% year-over-year to €844 million in Q3 2025, demonstrating strong cash generation that supports reinvestment and shareholder returns (Reuters)
On July 31, 2025, Siemens AG reduced its stake in Healthineers to 71.12%, expanding the free float. CEO Bernd Montag endorsed the move, saying that broader share ownership would strengthen long-term growth and liquidity for the stock (Reuters)
Despite strong Q3 performance, Siemens Healthineers highlighted ongoing geopolitical uncertainties as possible challenges to its business, pointing to exposure to trade tensions among major markets (Reuters)
Shares in Siemens Healthineers dropped 3.15% after Siemens AG lowered its stake to 71.12%, reflecting investor concerns about the immediate impact of the move (Reuters)
Siemens CFO Ralf Thomas indicated plans to sell up to another 5% of Healthineers’ shares to fund acquisitions, posing a dilution risk for current shareholders and potential pressure on earnings per share (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.

Siemens Health Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Siemens Health Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SHL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs